Last reviewed · How we verify

NCT06149143

Cardiac Performance System Data Collection Study - Minnesota

Recruiting now Last updated 17 April 2024
What this trial tests

trial testing Cardiac Performance System (NSR) in Cardiac Disease in 50 participants. Currently enrolling.

Timeline
3 October 2023
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorSensydia Corporation
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date3 October 2023
Primary completion30 June 2024
Estimated completion30 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sensydia Corporation

Who can join

22 and older, any sex, with Cardiac Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Application of Telemedicine in the Management of Cardiovascular Diseases: A Focus on Heart Failure.
    Mutirangura P, Patel D, Akram H, Hughes A, et al · · 2025 · PMID 40630466 · DOI 10.31083/rcm37835

Verify or expand the search:

Other trials of Cardiac Performance System (NSR)

Trials testing the same drug.

Other recruiting trials for Cardiac Disease

Currently open trials in the same condition.

Other Sensydia Corporation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06149143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing